PL3137622T3 - Sposoby redukowania spadku pojemności życiowej - Google Patents
Sposoby redukowania spadku pojemności życiowejInfo
- Publication number
- PL3137622T3 PL3137622T3 PL15785560T PL15785560T PL3137622T3 PL 3137622 T3 PL3137622 T3 PL 3137622T3 PL 15785560 T PL15785560 T PL 15785560T PL 15785560 T PL15785560 T PL 15785560T PL 3137622 T3 PL3137622 T3 PL 3137622T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- vital capacity
- reducing decline
- decline
- reducing
- Prior art date
Links
- 230000007423 decrease Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461985799P | 2014-04-29 | 2014-04-29 | |
| US201462006337P | 2014-06-02 | 2014-06-02 | |
| US201462022407P | 2014-07-09 | 2014-07-09 | |
| US201462094542P | 2014-12-19 | 2014-12-19 | |
| PCT/US2015/027897 WO2015168064A1 (en) | 2014-04-29 | 2015-04-28 | Methods of reducing decline in vital capacity |
| EP15785560.2A EP3137622B1 (en) | 2014-04-29 | 2015-04-28 | Methods of reducing decline in vital capacity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3137622T3 true PL3137622T3 (pl) | 2022-05-09 |
Family
ID=54359220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15785560T PL3137622T3 (pl) | 2014-04-29 | 2015-04-28 | Sposoby redukowania spadku pojemności życiowej |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20170042890A1 (pl) |
| EP (1) | EP3137622B1 (pl) |
| CY (1) | CY1124995T1 (pl) |
| DK (1) | DK3137622T3 (pl) |
| ES (1) | ES2906218T3 (pl) |
| HR (1) | HRP20220183T1 (pl) |
| HU (1) | HUE057533T2 (pl) |
| LT (1) | LT3137622T (pl) |
| PL (1) | PL3137622T3 (pl) |
| PT (1) | PT3137622T (pl) |
| RS (1) | RS63018B1 (pl) |
| SI (1) | SI3137622T1 (pl) |
| SM (1) | SMT202200096T1 (pl) |
| WO (1) | WO2015168064A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8299248B2 (en) | 2006-08-02 | 2012-10-30 | Cytokinetics, Incorporated | Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use |
| AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
| US9133123B2 (en) | 2010-04-23 | 2015-09-15 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| US10272082B2 (en) | 2011-07-13 | 2019-04-30 | Cytokinetics, Inc. | Combination ALS therapy |
| CN109069498B (zh) | 2016-02-12 | 2021-08-17 | 细胞动力学股份有限公司 | 四氢异喹啉衍生物 |
| AU2021373814A1 (en) | 2020-11-06 | 2023-05-25 | Cytokinetics, Inc. | Bicyclic 1,4-diazepanones and therapeutic uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2017357A (en) * | 1933-07-29 | 1935-10-15 | Firm Soc Alsacienne De Const M | Metal carriage for mule machines |
| US20100173930A1 (en) | 2006-08-01 | 2010-07-08 | Alex Muci | Certain Chemical Entities, Compositions and Methods |
| US8227603B2 (en) * | 2006-08-01 | 2012-07-24 | Cytokinetics, Inc. | Modulating skeletal muscle |
| KR101410453B1 (ko) | 2006-08-02 | 2014-06-27 | 싸이토키네틱스, 인코포레이티드 | 소정의 화학 물질, 조성물 및 방법 |
| US7851484B2 (en) | 2007-03-30 | 2010-12-14 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| US7989469B2 (en) | 2008-02-04 | 2011-08-02 | Cytokinetics, Incorporated | Certain chemical entities, compositions, and methods |
| US7998976B2 (en) | 2008-02-04 | 2011-08-16 | Cytokinetics, Inc. | Certain chemical entities, compositions and methods |
| AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
| US9133123B2 (en) | 2010-04-23 | 2015-09-15 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| US8759380B2 (en) | 2011-04-22 | 2014-06-24 | Cytokinetics, Inc. | Certain heterocycles, compositions thereof, and methods for their use |
| US10272082B2 (en) | 2011-07-13 | 2019-04-30 | Cytokinetics, Inc. | Combination ALS therapy |
| MX354965B (es) | 2012-04-02 | 2018-03-27 | Cytokinetics Inc | Metodo para mejorar la funcion del diafragma. |
| CN104395458A (zh) * | 2012-04-11 | 2015-03-04 | 赛特凯恩蒂克公司 | 改善对骨骼肌疲劳的抵抗力 |
| DE102012103489B4 (de) * | 2012-04-20 | 2015-11-12 | Maschinenfabrik Reinhausen Gmbh | Laststufenschalter und dessen Verwendung zur Spannungsregelung in einem Verteiltransformator |
-
2015
- 2015-04-28 PL PL15785560T patent/PL3137622T3/pl unknown
- 2015-04-28 HU HUE15785560A patent/HUE057533T2/hu unknown
- 2015-04-28 WO PCT/US2015/027897 patent/WO2015168064A1/en not_active Ceased
- 2015-04-28 US US15/306,981 patent/US20170042890A1/en not_active Abandoned
- 2015-04-28 DK DK15785560.2T patent/DK3137622T3/da active
- 2015-04-28 PT PT157855602T patent/PT3137622T/pt unknown
- 2015-04-28 HR HRP20220183TT patent/HRP20220183T1/hr unknown
- 2015-04-28 SM SM20220096T patent/SMT202200096T1/it unknown
- 2015-04-28 ES ES15785560T patent/ES2906218T3/es active Active
- 2015-04-28 SI SI201531795T patent/SI3137622T1/sl unknown
- 2015-04-28 EP EP15785560.2A patent/EP3137622B1/en active Active
- 2015-04-28 RS RS20220127A patent/RS63018B1/sr unknown
- 2015-04-28 LT LTEPPCT/US2015/027897T patent/LT3137622T/lt unknown
-
2022
- 2022-02-15 CY CY20221100129T patent/CY1124995T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3137622A4 (en) | 2018-01-10 |
| HRP20220183T1 (hr) | 2022-04-29 |
| EP3137622A1 (en) | 2017-03-08 |
| ES2906218T3 (es) | 2022-04-13 |
| PT3137622T (pt) | 2022-03-08 |
| SMT202200096T1 (it) | 2022-03-21 |
| CY1124995T1 (el) | 2023-01-05 |
| SI3137622T1 (sl) | 2022-05-31 |
| HUE057533T2 (hu) | 2022-05-28 |
| RS63018B1 (sr) | 2022-04-29 |
| EP3137622B1 (en) | 2021-11-24 |
| WO2015168064A1 (en) | 2015-11-05 |
| LT3137622T (lt) | 2022-04-25 |
| DK3137622T3 (da) | 2022-02-07 |
| US20170042890A1 (en) | 2017-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201410668D0 (en) | Improvements in or relating to stairlifts | |
| SG11201704473WA (en) | New methods and uses | |
| PL3137622T3 (pl) | Sposoby redukowania spadku pojemności życiowej | |
| HUE049981T2 (hu) | Terhelési módszer GPU-ban lévõ megosztott regiszterhez | |
| GB201521304D0 (en) | Tokenisation in cardholder - not - present transactions | |
| ZA201702488B (en) | Improvements in or relating to connecting devices | |
| IL251335A0 (en) | Piperidinylpyrazolopyrimidinones and their use | |
| GB2528907B (en) | Improvements in or relating to furniture | |
| GB2526621B (en) | Improvements in or relating to stairlifts | |
| GB2517846B (en) | Improvements in and relating to loudspeakers | |
| GB2529132B (en) | Improvements in or relating to stairlifts | |
| GB201408091D0 (en) | Methods and uses | |
| GB201400699D0 (en) | Improvements in or relating to servewear | |
| GB201523035D0 (en) | In terferometry | |
| GB201500399D0 (en) | Vital pad + | |
| GB201411150D0 (en) | Novel aptamers and therapeutic uses thereof | |
| GB201515924D0 (en) | Improvements in or relating to healthcare | |
| GB201418307D0 (en) | Improvements in or relating to stairlifts | |
| GB2530075B (en) | Improvements in and relating to eyewashing | |
| GB201404831D0 (en) | Animalistic studies in nature | |
| GB201417432D0 (en) | Improvements in and relating to pipe-breaking | |
| GB201412354D0 (en) | Improvements in and relating to loudspeakers | |
| GB201408062D0 (en) | Improvements in and relating to loudspeakers | |
| GB201412345D0 (en) | Improvements in and relating to devices | |
| GB201419593D0 (en) | Improvements in or relating to connecting devices |